Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
The contract, signed in the final days of the Biden administration, is designed to help Moderna develop and test the safety and efficacy of vaccines to protect against five subtypes of influenza ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Moderna reports larger-than-expected quarterly loss Revenue falls 66% but beats expectations FDA pauses norovirus vaccine trial after adverse event report Feb 14 (Reuters) - Moderna (MRNA.O ...
Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...
Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback